NewAmsterdam Pharma (NAMS) Earnings Date & Reports

A.I. Advisor

published Earnings

NAMS is expected to report earnings to rise 19.66% to -49 cents per share on November 11

NewAmsterdam Pharma NAMS Stock Earnings Reports

Q3'24

Est.

$-0.49

Q2'24

Beat

by $0.17

Q1'24

Missed

by $0.44

Q4'23

Beat

by $0.04

Q3'23

Beat

by $0.31

The last earnings report on August 07 showed earnings per share of -40 cents, beating the estimate of -57 cents. With 312.34K shares outstanding, the current market capitalization sits at 1.44B.

View a ticker or compare two or three

Compare

NAMS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NAMS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for NAMS (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Gooimeer 2-35

Phone

+31 352062971

Employees

Web

https://www.newamsterdampharma.com